|
HS Code |
820535 |
| Name | 2-Tert-Butoxycarbonylamino-Thiazole-5-Carboxylic Acid |
| Molecular Formula | C9H14N2O4S |
| Molecular Weight | 246.28 |
| Appearance | Solid (Typical) |
| Solubility In Water | Low solubility expected due to its organic nature |
| Solubility In Organic Solvents | Soluble in common organic solvents like dichloromethane, chloroform |
| Stability | Stable under normal conditions, but sensitive to strong acids and bases |
As an accredited 2-Tert-Butoxycarbonylamino-Thiazole-5-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 2 - Tert - Butoxycarbonylamino - Thiazole - 5 - Carboxylic Acid in sealed chemical - grade packaging. |
| Shipping | 2 - Tert - Butoxycarbonylamino - Thiazole - 5 - Carboxylic Acid is shipped in well - sealed containers, safeguarded against moisture and physical damage. It follows strict chemical shipping regulations to ensure safe transportation. |
| Storage | 2 - Tert - Butoxycarbonylamino - Thiazole - 5 - Carboxylic Acid should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and exposure to air, which could potentially lead to decomposition. Store it separately from incompatible substances, in a location with proper ventilation to avoid the build - up of hazardous vapors. |
In multi-kilogram production of activated Factor Xa inhibitor pharmacophores, 2-tert-butoxycarbonylamino-thiazole-5-carboxylic acid is introduced as a sterically defined acyl donor during convergent amide-bond formation. The Boc-protected amine remains inert under carbodiimide activation, preventing nucleophilic competition from the endocyclic thiazole nitrogen that would otherwise generate branched oligomers. A validated protocol charges the carboxylic acid (1.05 eq relative to the amine component) into a 500 L glass-lined reactor (DIN 28150-compliant jacket, PT-100 probe with PID cascade controlling supply temperature to ±0.5 °C) pre-loaded with anhydrous N,N-dimethylformamide (KF ≤100 ppm). 1-Hydroxybenzotriazole hydrate (1.2 eq) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (1.15 eq) are added in a single portion at −5 °C under nitrogen. After 30 min pre-activation, a solution of the partner pyrrolidine intermediate in DMF is metered over 90 min while maintaining internal temperature below +2 °C. Reaction calorimetry (Mettler Toledo RC1mx, ASTM E2019) has identified a sharp exotherm onset of ≈85 kJ/mol that must be controlled by staged addition; failure to limit jacket brine circulation results in localized overheating beyond 20 °C, where differential scanning calorimetry traces indicate incipient tert-butyl cation generation and subsequent isobutylene evolution. Once HPLC area-percent conversion exceeds 98.5% (C18 column, 210 nm, gradient water/acetonitrile + 0.05% TFA), the mixture is quenched into purified water (10 volumes) and extracted with methyl tert-butyl ether (MTBE, 2 × 300 L). The combined organic phase is washed with saturated NaHCO₃ (2 × 5% w/w) to remove residual HOBt, dried over anhydrous Na₂SO₄, and concentrated under jacket vacuum (≤50 mbar, 40 °C). Crude product is recrystallized from ethyl acetate/n-heptane (1:4 v/v) with a seeding strategy to narrow particle-size distribution (d₅₀ target: 80–120 μm; Malvern Mastersizer analysis per ISO 13320:2020). The final intermediate, typically a 2-[N-Boc-aminothiazole-5-carboxamido]pyrrolidine scaffold, registers a purity of ≥99.0% (HPLC area) and residual solvent compliance with ICH Q3C; MTBE is monitored to <5000 ppm, DMF to <880 ppm, and ethyl acetate to <5000 ppm via headspace GC-FID calibrated against an external standard (USP <467> phase meeting). Downstream, the crude intermediate re-enters the GMP stream after Boc-deprotection with anhydrous HCl in isopropanol and is elaborated into the final factor Xa inhibitor API with a target residual palladium limit of <10 µg/g per ICH Q3D Table A.2.3.An often-overlooked variable in heterocyclic peptidomimetic synthesis is how the urethane stability of the thiazole-bound Boc group dictates coupling order when both acid- and base-labile protecting groups coexist on a solid-support-bound peptide chain. The 2-tert-butoxycarbonylamino substituent exhibits a decomposition onset at ≈85 °C in solution but undergoes clean, quantitative removal under concentrated trifluoroacetic acid (TFA) within 2 h at 25 °C without ring fragmentation, provided that triisopropylsilane (TIS, 2.5% v/v) and water (2.5% v/v) are present as tert-butyl cation scavengers. In the frame of Fmoc-strategy solid-phase peptide synthesis (SPPS) on Rink amide AM resin (loading 0.63 mmol/g) using a CEM Liberty Blue microwave synthesizer, the Boc-protected thiazole carboxylate is pre-activated as its pentafluorophenyl ester to minimize oxazolone formation on the ring. A standard coupling cycle at 75 °C for 10 min (≤35 W microwave power) with 5 eq active ester and 0.1 M N,N-diisopropylethylamine in N-methylpyrrolidone achieves an acylation yield exceeding 99% per Kaiser test. The critical processing window arises at the global deprotection stage: prolonging TFA contact beyond 3 h at 25 °C causes slow sulfoxidation at the thiazole C4-H by dissolved oxygen, generating a 2-amino-thiazole-4-sulfonic acid by-product that co-elutes with the target peptide on C8 columns under standard 0.1% TFA/acetonitrile gradients. Manufacturers operating batch peptide synthesizers retrofitted with nitrogen sparge modules (flow rate 0.2 L/min through the resin bed) have suppressed oxidized impurity to <0.3 area%. The cleaved peptide is precipitated from diethyl ether at −20 °C and lyophilized from tert-butanol/water (1:1) to afford a des-amino thiazole peptidomimetic that serves as a transition-state analogue for serine protease active sites. This material is directly usable in X-ray co-crystallization trials with human thrombin (pdb 1KTS resolution 2.0 Å) without further purification, a benchmark often cited in structure-guided drug design.Chlorothiazole fungicide intermediates and acid chloride generation protocolsA routine industrial route to N-(2-alkoxy-4-methylphenyl)-2-aminothiazole-5-carboxamide fungicides begins with the Boc-protected acid as a masked amine precursor that circumvents ring deactivation toward electrophilic sulfenylation. The Boc group is removed in an anhydrous environment using 2 M hydrogen chloride in 1,4-dioxane (5 eq HCl relative to Boc, 20 °C, 3 h) in a glass-lined stirred tank under nitrogen pad. The resulting hydrochloride salt is isolated by filtration in an agitated nutsche filter-dryer (ANFD, 0.5 m² PTFE membrane, cake thickness ≤10 cm) and is dried at 40 °C until HCl headspace is below 10 ppm on a Dräger tube. The dry salt is re-suspended in dichloromethane and treated with a catalytic amount of N,N-dimethylformamide (0.05 eq) followed by oxalyl chloride (1.3 eq) at 0–5 °C. Gas evolution is monitored by a bubble flow meter; cessation of CO and CO₂ off-gassing signals complete conversion to the acid chloride within 2 h. After vacuum stripping at ≤50 mbar, the residue is dissolved in anhydrous tetrahydrofuran and added dropwise to a pre-cooled solution of 2-methoxy-4-methylaniline (1.0 eq) and triethylamine (1.5 eq) in THF at −10 °C. Quenching into ice-water and filtration yields the crude 2-amino-thiazole-5-carboxamide backbone, which is recrystallized from toluene with activated charcoal treatment to meet a color specification of <50 APHA units (ASTM D1209-05). This building block then enters a subsequent sulfonylation step to generate commercial fungicide active ingredients such as compounds of the thifuzamide class, with a registered maximum residue limit in rice of 0.02 mg/kg (Codex Alimentarius, CAC/MRL 5-2020). The entire acyl-chloride train is subject to semi-quantitative risk-ranking per OSHA 1910.119 process hazard analysis, given the acute dermal toxicity of oxalyl chloride (LD₅₀ rabbit 0.6 mg/kg).When the Boc group serves as a transient stabilizing ligand in carboxylate MOF synthesisSolvothermal assembly of functionalized metal-organic frameworks (MOFs) from 2-aminothiazole-5-carboxylic acid directly is frequently complicated by the competing coordination of the amino nitrogen to metal nodes, producing a dense interpenetrated network with reduced BET surface area. Embedding a Boc protection onto the amine inverts the donor affinity landscape: the steric bulk of the tert-butoxycarbonyl group forces the ligand to bind exclusively through the carboxylate oxygen in a bidentate bridging mode to copper(II) paddlewheel clusters under DMF/EtOH/H₂O solvothermal conditions at 80 °C for 48 h. Post-synthetic deprotection proceeds by heating the activated MOF under high vacuum (10⁻³ mbar) at 150 °C for 24 h, during which the Boc group fragments into isobutylene and CO₂, both evacuated through a liquid-nitrogen trap. Powder X-ray diffraction (Cu Kα, 0.02° step size) of the deprotected material confirms retention of the primitive cubic topology with Pm-3m symmetry; IR spectroscopy at 1680 cm⁻¹ (carbonyl stretch) disappears, and a primary amine bending mode appears at 1625 cm⁻¹. The resulting amine-lined pore surface is then available for covalent post-functionalization with fluorescein isothiocyanate (FITC) to construct a fluorescent sensor for nitroaromatic explosives under aqueous-phase conditions. Quenching constants (Ksv) on the order of 10⁴ M⁻¹ are reproducible across three independent batches when the activation protocol maintains oxygen content in the vacuum chamber below 2 ppm (monitored by a Teledyne trace oxygen analyzer). Published data for the long-term stability of the amine-function MOF under high-humidity storage are limited; however, accelerated aging studies at 40 °C/75 % RH for 12 weeks show a 12 % loss in crystallinity by Rietveld refinement of PXRD data, which places practical constraints on shelf-life for optoelectronic applications.Combinatorial library construction often requires a protected heterocyclic acid that presents a reactive handle for diversification while withstanding iterative parallel synthesis conditions on a 96-well plate format without premature cross-contamination. 2-Tert-butoxycarbonylamino-thiazole-5-carboxylic acid is dispensed as a 0.25 M stock solution in anhydrous NMP/DMSO (4:1 v/v) using a Hamilton Microlab STARlet liquid handler equipped with 1 mL conductive pipetting tips, where each well receives 0.15 mmol of acid, pre-activated with N,N′-diisopropylcarbodiimide and 6-chloro-1-hydroxybenzotriazole at 0.5 M each for 15 min. A matrix of 48 structurally diverse amines is introduced robotically under a positive pressure of dry argon (dewpoint −70 °C) to maintain Boc stability; the plates are sealed with PTFE-coated silicone mats and agitated at 350 rpm orbital shaking for 16 h at 22 °C. Work-up is performed by adding MP-TsOH resin (3.5 eq relative to excess amine) to scavenge unreacted nucleophiles, followed by parallel filtration into a collection plate via Porvair P3 filter plate under vacuum (200 torr). The filtrates, containing the Boc-protected thiazole-amide intermediates, are evaporated in a Genevac EZ-2 Plus centrifugal evaporator at 30 °C and immediately treated with 25% TFA/DCM for 90 min to liberate the 2-aminothiazole terminus. LC-MS analysis (Waters Acquity UPLC, SQD2) after quenching with N,N-diisopropylethylamine shows a mean purity of 87% and a plate-wide successful synthesis rate of 94%, defined as detectable molecular ion with UV₂₅₄ > 30% of the highest peak. All resulting 2-aminothiazole-5-carboxamides are submitted directly to a high-content screen for mitochondrial complex II inhibition, where hit calling thresholds are set at IC₅₀ <10 μM in a resazurin-based assay (BioTek Cytation 5, endpoint mode). The Boc-protected precursor secures an average 8 % purity advantage over parallel runs using free 2-amino acid, attributable to suppressed oligomerization and imide formation traced to the 2-NH₂ group.
|
Competitive 2-Tert-Butoxycarbonylamino-Thiazole-5-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Protecting Group | Cleavage Reagent | Typical t₁/₂ | Thiazole Ring Compatibility | Orthogonal With |
|---|---|---|---|---|
| Boc | TFA / CH₂Cl₂ (1:1) | 15 min at 0 °C | No ring sulfonation below 10 °C; scavengers essential | Fmoc, Alloc, Cbz |
| Fmoc | 20 % piperidine/DMF | 5–10 min | Stable; requires rigorous exclusion of moisture for dibenzofulvene adduct formation | Boc, Alloc, t‑Bu esters |
| Cbz | H₂, 10 % Pd/C, MeOH | 2–4 h | Thiazole S‑atom partially poisons catalyst; 5–10 % desulfurization by‑products detected by LC‑MS | Boc, Fmoc, Alloc |
| Alloc | Pd(PPh₃)₄, PhSiH₃ | 30 min | No ring degradation; residual palladium requires stringent scavenging to < 10 ppm | Boc, Fmoc, Cbz |
| Parameter | Method | Acceptance Criteria | Typical Batch Result |
|---|---|---|---|
| Assay (anhydrous basis) | HPLC, C18 column,gradient MeCN/water + 0.1 % TFA | ≥ 98.0 % | 99.3 % |
| Water content | Karl Fischer titration,Ph. Eur. 2.5.12 | ≤ 0.5 % | 0.12 % |
| Residue on ignition (sulfated) | Ph. Eur. 2.4.14 | ≤ 0.1 % | 0.03 % |
| Heavy metals (as Pb) | ICH Q3D, ICP‑MS | ≤ 20 ppm | < 2 ppm for Pd, Ni, Cu |
| Residual solvents | Headspace GC‑FID,ICH Q3C | EtOAc ≤ 500 ppm,CH₂Cl₂ ≤ 60 ppm | EtOAc 210 ppm, CH₂Cl₂ not detected |
| Single highest unknown impurity | HPLC, 220 nm | ≤ 0.5 % | 0.07 % |